article thumbnail

What to expect from PEGS Europe 2023: Day 1

Drug Discovery World

Presentations include: Marjolein van Egmond, PhD, Professor, Oncology and Inflammation, Surgery/Molecular Cell Biology and Immunology, Amsterdam UMC, on: ‘Novel FcαRI bispecific antibody immunocytokines for the recruitment of myeloid effector cells in cancer therapy’. Claes Gustafsson, Ph.D,

article thumbnail

What to expect from PEGS Europe 2023: Day 3

Drug Discovery World

Sandeep Talapatra, PhD, Leader Protein Science, Protein Cell & Structural Sciences, GSK, on: ‘Enhancing success rates and throughput of protein purification for drug discovery: A medium-scale approach’. These topics include: High-throughput (HTP) protein production and AI and automation in bioprocess development.